Medgenics Inc. (MDGN) Financials Nov 14, 2014, 3:59 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Medgenics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 120,483 120,000 98,000 - 177,000
COGS excluding D&A 0 0 0 - 0
Depreciation & Amortization Expense 120,483 120,000 98,000 145,000 177,000
Depreciation 120,483 120,000 98,000 145,000 177,000
Amortization of Intangibles 0 0 0 0 0
Gross Income (120,483) (120,000) (98,000) - (177,000)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 3.74M 5.81M 9.88M 14.24M 17.46M
Research & Development 1.32M 1.53M 5.05M 7.19M 7.3M
Other SG&A 2.42M 4.29M 4.83M 7.05M 10.16M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 633,000 (1.94M) 2.34M (534,000)
EBIT after Unusual Expense 0 (633,000) 1.94M (2.34M) 534,000
Non Operating Income/Expense (48,281) 2.59M 10,000 (93,000) (17,000)
Non-Operating Interest Income 2,578 3,000 8,000 5,000 3,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 501,050 174,000 71,000 0 0
Gross Interest Expense 501,050 174,000 71,000 0 0
Interest Capitalized 0 0 0 - -
Pretax Income (4.41M) (4.15M) (8.09M) (16.81M) (17.11M)
Income Tax 1,043 2,000 3,000 (1.74M) 17,000
Income Tax - Current Domestic 1,043 2,000 - (1.74M) 17,000
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (4.41M) (4.15M) (8.1M) (15.07M) (17.13M)
Minority Interest Expense 0 0 0 0 0
Net Income (4.41M) (4.15M) (8.1M) (15.07M) (17.13M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (4.41M) (4.15M) (8.1M) (15.07M) (17.13M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (4.41M) (4.15M) (8.1M) (15.07M) (17.13M)
EPS (Basic) (1.40) (0.95) (0.96) (1.37) (0.97)
Basic Shares Outstanding 3.37M 4.37M 8.45M 11.02M 17.63M
EPS (Diluted) (1.40) (0.95) (0.96) (1.37) (1.06)
Diluted Shares Outstanding 3.37M 4.37M 8.45M 11.02M 17.68M
EBITDA (3.74M) (5.81M) (9.88M) (14.24M) (17.46M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Medgenics Inc.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 0 0 0 0 0
Cost of Goods Sold (COGS) incl. D&A 120,483 120,000 98,000 - 177,000
COGS excluding D&A 0 0 0 - 0
Depreciation & Amortization Expense 120,483 120,000 98,000 145,000 177,000
Depreciation 120,483 120,000 98,000 145,000 177,000
Amortization of Intangibles 0 0 0 0 0
Gross Income (120,483) (120,000) (98,000) - (177,000)
2009 2010 2011 2012 2013 5-year trend
SG&A Expense 3.74M 5.81M 9.88M 14.24M 17.46M
Research & Development 1.32M 1.53M 5.05M 7.19M 7.3M
Other SG&A 2.42M 4.29M 4.83M 7.05M 10.16M
Other Operating Expense 0 0 0 0 0
Unusual Expense 0 633,000 (1.94M) 2.34M (534,000)
EBIT after Unusual Expense 0 (633,000) 1.94M (2.34M) 534,000
Non Operating Income/Expense (48,281) 2.59M 10,000 (93,000) (17,000)
Non-Operating Interest Income 2,578 3,000 8,000 5,000 3,000
Equity in Affiliates (Pretax) 0 0 0 0 0
Interest Expense 501,050 174,000 71,000 0 0
Gross Interest Expense 501,050 174,000 71,000 0 0
Interest Capitalized 0 0 0 - -
Pretax Income (4.41M) (4.15M) (8.09M) (16.81M) (17.11M)
Income Tax 1,043 2,000 3,000 (1.74M) 17,000
Income Tax - Current Domestic 1,043 2,000 - (1.74M) 17,000
Income Tax - Current Foreign 0 0 - - -
Income Tax - Deferred Domestic 0 0 - - -
Income Tax - Deferred Foreign 0 0 - - -
Income Tax Credits 0 0 0 - -
Equity in Affiliates 0 0 0 0 0
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income (4.41M) (4.15M) (8.1M) (15.07M) (17.13M)
Minority Interest Expense 0 0 0 0 0
Net Income (4.41M) (4.15M) (8.1M) (15.07M) (17.13M)
Extraordinaries & Discontinued Operations 0 0 0 0 0
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 0
Net Income After Extraordinaries (4.41M) (4.15M) (8.1M) (15.07M) (17.13M)
Preferred Dividends 0 0 0 0 0
Net Income Available to Common (4.41M) (4.15M) (8.1M) (15.07M) (17.13M)
EPS (Basic) (1.40) (0.95) (0.96) (1.37) (0.97)
Basic Shares Outstanding 3.37M 4.37M 8.45M 11.02M 17.63M
EPS (Diluted) (1.40) (0.95) (0.96) (1.37) (1.06)
Diluted Shares Outstanding 3.37M 4.37M 8.45M 11.02M 17.68M
EBITDA (3.74M) (5.81M) (9.88M) (14.24M) (17.46M)
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
